CD Biosciences Provides Peptidomimetic Development Services to FacilitateTherapeutic Development

CD Biosciences, the leading biotechnology institution focus on delivering a broad range of products and services and striving for solutions that improve research outcomes and dramatically increase the speed of success. With millions of researchers and partners worldwide, CD Biosciences supports pharmaceutical companies with a wide range of high-quality and reliable peptidomimetic development products and comprehensive service packages to promote basic scientific research and drug development. Recently, CD Biosciences announced the release of its peptidomimetic development services to facilitate therapeutical development.

CD BioSciences has long been committed to using the advanced PepDom platform to design and synthesize peptidomimetics according to customers' specific requirements, including but not limited to:

CD BioSciences can conduct rational peptidomimetic design based on the targets revealed in life science research, or the chemical structure characteristics of their endogenous ligands and natural substrates, and discover drug lead compounds that selectively act on the target. CD BioSciences provides comprehensive peptidomimetic development services for signaling molecules, transcription factors, receptors, and enzymes.

CD BioSciences also provides function-based peptide development services, mainly including antimicrobial peptide development services, antiviral peptide development services, anticancer peptide development services, antioxidant peptide development services, etc. Rational peptidomimetic design can be rationally changed and modified according to the functional properties of the initial peptide to obtain ideal stability or other properties, as a lead compound for new drug development.

CD BioSciences provides professional solutions from peptidomimetic design to verification of each link, covering peptidomimetic development services in research fields such as scientific research and pharmaceuticals, and provides peptidomimetic development services based on diverse functions or mechanisms of action.

“We are committed to offering satisfactory assistance to our customers in biological, chemical and pharmaceutical research.” said Marcia Brady, the marketing director of CD Biosciences, “We will continue to combine multidisciplinary knowledge and continue to expand the content and scope of our services to meet changing future research needs.”

About CD Biosciences

CD BioSciences has top scientific researchers and the most professional service team, and has already established connections with millions of researchers and partners worldwide with a wide range of high-quality and reliable peptidomimetic development products and comprehensive service packages to promote basic scientific research and drug development.